SITAGLIPTIN HYDROCHLORIDE ORAL Drug Interactions
Also known as: BRYNOVIN
SITAGLIPTIN HYDROCHLORIDE ORAL (brand name: BRYNOVIN) is a DPP-4 Inhibitors. 1 INDICATIONS & USAGE BRYNOVIN is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use BRYNOVIN is not recommended in patients with type 1 diabetes. BRYNOVIN has not been studied in patients with a history of…No drug interactions are currently documented in our database for SITAGLIPTIN HYDROCHLORIDE ORAL. This does not mean interactions don't exist — always consult your pharmacist.
No interactions documented yet for SITAGLIPTIN HYDROCHLORIDE ORAL.
For complete prescribing information:
View full SITAGLIPTIN HYDROCHLORIDE ORAL monograph →Medical Disclaimer
The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.